Xcout Intel
4BASEBIO PLC competitors & alternatives
The 12 closest competitors and alternatives to 4BASEBIO PLC among biotech companies — ranked by similarity to what 4BASEBIO PLC actually does, not by market-cap band.
Subscribe to see 4BASEBIO PLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About 4BASEBIO PLC
4basebio PLC, an enterprise established in 2020 and situated in Cambridge, United Kingdom, is dedicated to the entire process, from conception to delivery, of synthetic DNA and RNA products. The company also provides advanced non-viral vector solutions, with operations spanning the United States, Europe, and other international markets. Their comprehensive offerings encompass research kits, bulk enzymes, various other biological products, as well as crucial licensing and AVV manufacturing services. The company primarily caters to clients within the biotech, pharmaceutical, and contract development and manufacturing organization (CDMO) industries. Notably, the firm adopted its current name, 4basebio PLC, in July 2021, having previously been known as 4basebio UK Societas.
4BASEBIO PLC at a glance
4BASEBIO PLC is a biotech company headquartered in Cambridge, United Kingdom, founded in 2020. It is publicly listed (4BB) with a market capitalisation of $103.2M. Xcout tracks 13 named people at 4BASEBIO PLC, including Amy Walker (Chief Executive Officer).
4BASEBIO PLC leadership
- Amy WalkerChief Executive Officer
- Scott LorimerChief Operating Officer
- Christine WolosinChief Commercial Officer
- Richard BungayChief Finance Officer
- Luis BlancoScientific Founder
- Daniel JonesVice President, Manufacturing & Engineering
7 more named people on record for 4BASEBIO PLC, with roles, board committees and tenure — see the full roster →
Top 12 4BASEBIO PLC competitors
Ranked by semantic similarity — how close each company is to 4BASEBIO PLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Operating as an investment holding company, Genscript Biotech Corporation, established in 2002 and headquartered in Nanjing, People's Republic of China, specializes in the global provision of innovative life science research solutions, encompassing both products and services. Its market presence spans North America, Europe, China, Japan, other Asia Pacific regions, and numerous international markets. The enterprise structures its operations into four key divisions: The Life Science Services and Products segment delivers a wide array of research offerings, such as gene and oligonucleotide synthesis, molecular cloning, protein and peptide engineering, antibody production, molecular diagnostic instruments, and genomic editing materials. These resources are instrumental for fundamental biological investigations, pharmaceutical and drug discovery, disease diagnostics, vaccine development, and applications in agriculture, environmental science, and food production. The Biologics Development Services division supports pharmaceutical, biotechnology, governmental, and academic institutions. It provides comprehensive services for the full lifecycle of therapeutic antibodies, from initial discovery through pre-clinical and clinical development, alongside pre-clinical and clinical development for plasmids and viruses, and broader gene and cell therapy development. Dedicated to industrial applications, the Industrial Synthetic Biology Products segment engineers non-pathogenic microbial strains and manufactures specialized enzymes. These enzymes find utility across the food processing, animal feed, pharmaceutical, and chemical sectors. Finally, the Cell Therapy unit focuses on the pioneering discovery and advanced development of chimeric antigen receptor T-cell (CAR-T) therapies, specifically designed to combat both liquid and solid malignant tumors.
Similar biotech company
DNA Script develops enzymatic DNA synthesis technology, offering the SYNTAX platform and associated kits that enable laboratories to produce high-quality oligonucleotides in-house and on-demand. The company serves biotech companies, pharmaceutical firms, contract research organizations, core facilities, and governmental agencies seeking to streamline synthetic biology workflows.
Similar biotech company
Source BioScience is a UK-based laboratory services company providing genomics, DNA sequencing, molecular diagnostics, and pathology-related testing. It serves pharmaceutical and biotechnology companies, healthcare organizations, research institutions, and other life-science customers.
Biotechnology
DINYA DNA provides a next-generation DNA synthesis platform that utilizes a multi-enzyme process to directly create long and complex double-stranded DNA molecules without requiring traditional oligo assembly. The company serves scientists and researchers by delivering custom DNA sequences with fast turnaround times and minimal complexity limitations.
Similar biotech company
New England Biolabs, Inc. (NEB) is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase.
Similar biotech company
Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Biotechnology
Synhelix is a French biotechnology company founded in 2019 to develop affordable DNA synthesis technology and address the supply bottleneck of DNA constructs for biotherapeutics development. The company was acquired by Univercells to be incorporated into its affiliate Quantoom, expanding its operations into synthetic biology.
Medical - Diagnostics & Research
Twist Bioscience Corp is headquartered in South San Francisco, California, and operates in the synthetic biology sector. The company manufactures and sells customized DNA synthesis products utilizing a silicon-based platform for various scientific applications.
Similar biotech company
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Life Sciences
Ansa Biotechnologies, Inc. is a biotechnology research company located in Emeryville, California. The company specializes in developing advanced high-fidelity custom DNA synthesis technologies and products.
Similar biotech company
Integrated DNA Technologies manufactures and supplies custom nucleic acid products, including DNA and RNA oligonucleotides, qPCR assays, CRISPR genome editing tools, gene fragments, and next-generation sequencing reagents. The company serves researchers and life science professionals in academic, clinical, and industrial sectors.
Life Sciences, Diagnostics
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of 4BASEBIO PLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for 4BASEBIO PLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →